Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID<sup>®</sup>) with Concomitant Medications in Real-World Clinical Settings
Background: This research article delves into the battle against the COVID-19 pandemic, focusing on the efficacy and, particularly, the safety of the combination of nirmatrelvir with ritonavir, which is found in the pharmaceutical product Paxlovid<sup>®</sup>. This study aims to analyze the potentia...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2024-11-01
|
| Serija: | Pathogens |
| Teme: | |
| Online dostop: | https://www.mdpi.com/2076-0817/13/12/1055 |
| Oznake: |
Brez oznak, prvi označite!
|